LIVER FIBROSIS IN CHRONIC HEPATITIS B

Clinical trials for LIVER FIBROSIS IN CHRONIC HEPATITIS B explained in plain language.

Never miss a new study

Get alerted when new LIVER FIBROSIS IN CHRONIC HEPATITIS B trials appear

Sign up with your email to follow new studies for LIVER FIBROSIS IN CHRONIC HEPATITIS B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

5-Year quest to halt liver damage in hepatitis b patients

Disease control Not yet recruiting

This large, 5-year study aims to see if adding the drug Hydronidone to standard antiviral therapy can prevent serious liver complications in people with chronic hepatitis B who already have liver scarring (fibrosis). It will involve about 1,200 adults and compare Hydronidone agai…

Matched conditions: LIVER FIBROSIS IN CHRONIC HEPATITIS B

Phase: PHASE3 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control

Last updated Mar 24, 2026 12:03 UTC

LIVER FIBROSIS IN CHRONIC HEPATITIS B

Get alerted when new LIVER FIBROSIS IN CHRONIC HEPATITIS B trials appear

5-Year quest to halt liver damage in hepatitis b patients